Abstract
BackgroundAlzheimer’s disease (AD) is the leading cause of dementia. Currently, there are no effective disease-modifying treatments for AD. Mendelian randomisation (MR) has been widely used to repurpose licensed drugs and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have